viral
hepat
remain
common
caus
liver
diseas
major
public
health
problem
focu
role
doubl
neg
dn
cell
involv
mechan
viral
persist
hepat
mice
infect
murin
hepat
viru
strain
use
display
chronic
viral
hepat
dn
cell
dramat
increas
infect
mice
adopt
transfer
dn
cell
infect
mice
led
signific
increas
mice
surviv
dn
cell
product
ifnc
abl
kill
virusspecif
cell
via
fasfasl
depend
pathway
delic
balanc
multipl
effect
dn
cell
may
lead
viral
persist
induc
hepat
short
studi
identifi
dn
cell
contribut
viral
persist
induc
hepat
mice
provid
rational
modul
dn
cell
manag
viral
hepat
viral
hepat
remain
major
public
health
problem
world
consider
morbid
mortal
estim
million
carrier
hepat
b
viru
hbv
million
carrier
hepat
c
viru
hcv
worldwid
persist
infect
may
progress
chronic
liver
diseas
cirrhosi
primari
liver
cancer
viral
protein
express
hepatocyt
may
influenc
sever
progress
liver
diseas
howev
extens
studi
suggest
mechan
liver
injuri
viral
hepat
due
host
immun
respons
direct
cytopath
effect
virus
direct
kill
infect
cell
virusspecif
cytotox
lymphocyt
ctl
consid
central
mechan
result
liver
damag
viru
control
addit
helper
respons
also
found
strong
associ
viral
clearanc
acut
phase
hepat
viral
persist
hepat
infect
may
direct
result
weak
antivir
immun
respons
viral
antigen
correspond
inabl
erad
viru
within
infect
cell
accumul
evid
indic
regulatori
treg
cell
play
import
role
suppress
viru
specif
immun
respons
mani
subset
treg
cell
studi
includ
treg
cell
agspecif
cell
secret
immunoregulatori
cytokin
cell
tgfb
cell
tcrcd
cell
tcrab
doubleneg
dn
cell
among
treg
cell
treg
extens
studi
transcript
factor
consid
optim
marker
classic
natur
treg
patient
hbv
hcv
infect
treg
increas
level
impair
immun
respons
direct
hepat
virus
lead
persist
infect
chronic
liver
injuri
late
shalev
et
al
report
adopt
transfer
treg
mice
mice
result
increas
mortal
infect
demonstr
critic
role
treg
pathogenesi
induc
fulmin
hepat
dn
cell
novel
subset
treg
cell
first
identifi
zhang
colleagu
mice
dn
treg
cell
could
kill
activ
cell
tcr
specif
infus
vitroactiv
dn
treg
cell
led
signific
prolong
donorspecif
skin
heart
graft
surviv
recent
increas
attent
focus
novel
treg
cell
et
al
demonstr
dn
cell
produc
contribut
pathogenesi
kidney
damag
patient
sle
anoth
studi
show
dn
splenic
cell
young
nod
mice
could
provid
longlast
protect
type
diabet
sivinduc
cell
deplet
sooti
mangabey
present
immun
dysfunct
clinic
aid
dn
cell
partial
compens
cell
function
anim
cutan
leishmaniasi
infect
tcrab
dnt
cell
present
increas
bia
capac
induc
inflammatori
immun
respons
tcrcd
dnt
cell
show
regulatori
profil
present
studi
investig
characterist
contribut
splenic
dn
cell
induc
chronic
viral
hepat
murin
model
studi
provid
rational
modul
dn
cell
manag
viral
hepat
anim
studi
carri
accord
guidelin
chines
council
anim
care
approv
tongji
hospit
tongji
medic
school
committe
anim
experiment
obtain
american
type
cultur
collect
atcc
plaquepurifi
monolay
dbt
cell
titer
cell
use
standard
plaqu
assay
mice
purchas
shanghai
laboratori
anim
center
chines
academi
scienc
shanghai
roc
individu
inject
periton
caviti
mice
previous
describ
peripher
blood
liver
obtain
differ
time
point
infect
mice
receiv
nacl
use
control
surviv
serum
biochemistri
paramet
includ
alt
ast
tp
alb
liver
histolog
observ
viru
titer
determin
liver
tissu
infect
mice
variou
time
point
standard
plaqu
assay
describ
blood
spleen
liver
collect
infect
mice
indic
day
post
infect
time
point
triplic
sampl
examin
mice
treat
nacl
use
control
threecolor
cytofluorometr
analysi
perform
facsaria
flow
cytomet
bd
bioscienc
san
jose
ca
usa
experi
approxim
l
singl
cell
suspens
process
pbmc
spleen
liver
stain
ebiosci
san
diego
ca
usa
monoclon
antibodi
correspond
isotyp
antibodi
use
control
five
day
infect
three
group
mice
group
mice
treat
respect
dn
cell
splenocyt
dn
tdeplet
splenocyt
infect
mice
via
tail
vein
anoth
mice
treat
pb
use
control
liver
tissu
sampl
recipi
mice
group
mice
group
harvest
stain
h
e
day
post
adopt
transfer
knodel
hepat
activ
index
hai
use
evalu
sever
necroinflamm
knodel
hai
score
consist
four
separ
score
includ
periport
necrosi
without
bridg
necrosi
intralobular
degener
focal
necrosi
portal
inflamm
fibrosi
viru
titer
liver
tissu
recipi
mice
group
test
standard
plaqu
assay
indic
time
point
express
dn
cell
surfac
marker
determin
flow
cytometri
analysi
cell
suspens
process
spleen
mice
day
post
infect
stain
apcantitcrb
peantitcrcd
monoclon
antibodi
isotyp
control
ab
ebiosci
san
diego
ca
usa
cell
harvest
spleen
infect
hej
mice
flow
cytometr
detect
intracellular
cytokin
perform
previous
describ
cell
stimul
lmoll
ionomycin
ngml
pma
presenc
monensin
lgml
h
co
cell
wash
fix
ml
icecold
paraformaldehyd
min
initi
stain
cellstub
wash
saponinpb
buffer
permeabil
plasma
intracellular
membran
peantiifnc
peantitnfa
peantiperforin
peantigranzym
b
isotypematch
irrelev
control
ab
ebiosci
san
diego
ca
usa
respect
ad
suspens
incub
min
two
wash
saponinpb
buffer
cell
stain
ebiosci
san
diego
ca
usa
min
cell
analyz
flow
cytometri
spleen
mice
made
suspens
incub
magnet
bead
sort
buffer
nont
cell
ie
b
cell
nk
cell
dendrit
cell
macrophag
magnet
label
cocktail
biotinconjug
antibodi
antibiotin
microbead
miltenyi
biotec
cologn
germani
isol
highli
pure
cell
achiev
deplet
magnet
label
cell
use
cell
isol
kit
miltenyi
biotec
cologn
germani
cell
isol
cell
obtain
previous
deplet
cell
neg
select
cell
isol
cell
use
cell
isol
kit
miltenyi
biotec
cologn
germani
unlabel
cell
dn
cell
cytotox
dn
cell
measur
use
cytotox
nonradioact
cytotox
assay
kit
promega
madison
wi
usa
follow
manufactur
instruct
cytotox
kit
measur
lactat
dehydrogenas
ldh
activ
releas
cultur
medium
lyse
cell
specif
cell
normal
cell
infect
hepatocyt
normal
hepatocyt
use
target
cell
dn
cell
use
effector
cell
experi
repeat
fasl
blockad
antimfasl
antibodi
r
minneapoli
mn
usa
ratio
dnt
cell
cell
mice
infect
smith
strain
murin
cytomegaloviru
mcmv
taken
unrel
control
cell
isol
spleen
mice
post
mcmv
infect
cytotox
effect
dn
cell
spleen
infect
mice
cell
spleen
mcmv
infect
mice
examin
dn
cell
cell
isol
spleen
infect
mice
transwel
corn
lowel
usa
experi
conduct
well
ml
complet
tissu
cultur
medium
semiperm
membran
separ
upper
lower
chamber
allow
diffus
solubl
materi
cell
measur
effect
noncontact
cytotox
dn
cell
cell
cell
cultur
lower
chamber
dn
cell
upper
chamber
cell
cultur
lower
chamber
alon
control
incub
period
h
cell
stain
wash
stain
apcantiannexin
v
bender
med
system
vienna
austria
pi
jingmei
biotech
shanghai
china
least
event
collect
annexin
vpi
analysi
approach
percent
annexin
v
pi
event
viabl
cell
popul
use
correct
spontan
apoptosi
follow
formula
cytotox
control
viabl
cell
coincub
viabl
cell
control
viabl
cell
result
reflect
rate
cell
undergo
apoptosisdeath
time
sampl
data
present
mean
sem
comparison
data
perform
use
student
twotail
ttest
oneway
analysi
varianc
anova
follow
studentnewman
keul
test
statist
packag
social
scienc
spss
use
data
analysi
case
signific
determin
p
order
investig
role
dn
cell
antivir
respons
develop
chronic
hepat
model
infect
mice
formerli
report
first
time
extens
character
diseas
chronic
liver
function
patholog
viral
hepat
model
infect
mice
began
anorexia
acratia
day
post
infect
day
day
post
infect
approxim
mice
die
survivor
becam
persist
infect
afterward
fig
viru
liver
tissu
infect
mice
could
detect
whole
cours
observ
viru
replic
peak
day
decreas
maintain
low
level
fig
variou
degre
hydrop
degener
hepatocellular
necrosi
inflammatori
infiltr
observ
liver
mice
day
infect
sever
liver
injuri
observ
day
dramat
impair
liver
function
includ
increas
alt
ast
well
decreas
total
protein
albumin
tabl
hepatocellular
injuri
surviv
mice
allevi
accompani
less
infiltr
improv
liver
function
inflammatori
chang
could
still
observ
liver
survivor
period
observ
fig
proport
dn
cell
blood
liver
spleen
rose
significantli
infect
mice
fig
c
peak
day
decreas
gradual
absolut
count
dn
cell
either
liver
spleen
present
similar
chang
proport
fig
adopt
transfer
dn
cell
infect
mice
increas
surviv
rate
improv
liver
histolog
recipi
mice
infect
viru
strain
littl
impact
viru
titer
liver
tissu
fig
show
signific
differ
viru
titer
liver
tissu
observ
among
dn
cell
group
splenocyt
group
dntdeplet
splenocyt
group
pb
control
group
adopt
transfer
either
dn
cell
splenocyt
infect
mice
surviv
rate
recipi
mice
rais
notabl
respect
mice
receiv
pb
mice
receiv
dn
tdeplet
splenocyt
surviv
fig
shown
fig
mice
receiv
dn
cell
splenocyt
allevi
hydrop
degener
inflammatori
cell
infiltr
well
bridg
necrosi
liver
compar
mice
receiv
pb
dn
tdeplet
splenocyt
compar
splenocyt
group
hepatocyt
swell
recipi
mice
dn
cell
group
much
sever
comparison
knodel
score
hai
among
four
group
day
adopt
transfer
shown
fig
signific
differ
found
dn
cell
group
vs
dntdeplet
splenocyt
group
versu
p
dn
cell
group
vs
pb
control
group
versu
p
character
dn
cell
detect
cell
surfac
marker
dn
cell
spleen
mice
post
infect
fig
major
dn
cell
express
tcrab
small
part
express
tcrcd
adhes
molecul
highli
express
dn
cell
activ
marker
rare
detect
moreov
dn
cell
recogn
nkt
cell
agspecif
fashion
demonstr
dn
cell
differ
nkt
cell
data
shown
intracellular
cytokin
dn
cell
detect
day
infect
infect
dn
cell
either
produc
ifnc
increas
sinc
day
infect
peak
day
maintain
stabl
level
henc
margin
level
tnfa
perforin
granzym
b
detect
signific
differ
infect
noninfect
mice
express
intracellular
cytokin
time
point
fig
c
cytotox
effect
dn
cell
spleen
mice
day
infect
examin
dnt
cell
signific
cytotox
effect
infect
cell
appar
effect
infect
hepatocyt
noninfect
cell
hepatocyt
fig
investig
cytotox
specif
dn
cell
murin
cytomegaloviru
mcmv
use
unrel
control
periton
mcmv
infect
liver
mice
evid
infect
mcmv
viru
replic
observ
liver
reveal
standard
plaqu
assay
data
shown
dn
cell
spleen
infect
mice
show
obviou
cytotox
effect
cell
spleen
mcmvinfect
mice
strongli
suggest
dn
cell
specif
kill
cell
viru
specif
effect
due
bystand
cytotox
fig
transwel
experi
perform
determin
whether
cytotox
effect
contactdepend
mediat
cytokin
result
show
dn
cell
cytotox
remark
weaker
dn
cell
cell
differ
chamber
oppos
chamber
fig
identifi
precis
mechan
involv
dn
cell
cytotox
express
fasl
perforin
granzym
b
dn
cell
studi
perforin
granzym
b
rare
detect
fig
dn
cell
express
fasl
moreov
dnt
cell
cytotox
dramat
decreas
fasl
block
effector
target
fig
lack
adequ
anim
model
long
major
obstacl
studi
viral
hepat
chimpanze
primat
suscept
hepat
virus
endang
statu
financi
consider
limit
widespread
use
research
also
use
surrog
anim
model
ground
squirrel
duck
tamarin
woodchuck
addit
wildtyp
anim
model
inbr
strain
anim
valuabl
investig
pathogenesi
viral
infect
transgen
mous
model
well
immunodefici
mice
toler
mice
rat
transplant
human
hepatocyt
hepatoma
cell
anim
model
mention
enabl
us
better
understand
pathogenesi
viral
hepat
limit
use
produc
straindepend
viral
hepat
inbr
strain
mice
brought
insight
pathogenesi
viral
hepat
group
other
belong
coronaviru
famili
singlestrand
positivesens
rna
genom
report
suscept
inbr
mous
strain
balbcj
develop
fulmin
hepat
die
within
day
follow
periton
inocul
viru
contrast
aj
mice
resist
develop
clinic
sign
hepat
clear
viru
within
day
infect
mous
semisuscept
mous
strain
develop
acut
hepat
progress
mild
chronic
hepat
studi
mice
present
acut
inflamm
day
infect
proport
infect
mice
die
howev
phase
liver
injuri
surviv
mice
allevi
accompani
recoveri
liver
function
mild
inflamm
observ
liver
survivor
persist
lowlevel
viru
replic
suggest
persist
viral
infect
sinc
diseas
cours
histopatholog
serum
biochem
chang
observ
mous
model
similar
observ
patient
chronic
viral
hepat
mous
model
could
use
understand
pathogenesi
chronic
viral
hepat
human
host
immun
respons
exercis
great
influenc
pathogenesi
outcom
viral
hepat
virus
elimin
host
immun
system
acut
phase
infect
certain
virus
like
hbv
hcv
evad
host
immun
respons
result
viral
persist
order
better
understand
mechan
lead
viru
persist
model
infect
mice
studi
variat
differ
subgroup
cell
mice
infect
result
show
frequenc
dn
cell
rose
significantli
blood
liver
spleen
infect
also
observ
increas
treg
data
shown
liver
increas
dn
cell
pronounc
increas
treg
indic
dn
cell
might
play
critic
role
control
pathogenesi
diseas
base
observ
liver
injuri
infect
mice
began
around
day
infect
assum
adopt
transfer
dn
cell
time
point
might
interfer
develop
liver
injuri
therefor
chose
transfer
dn
cell
recipi
mice
day
post
infect
result
demonstr
dn
cell
could
lead
dramat
increas
surviv
rate
recipi
mice
amelior
liver
histolog
howev
differ
viru
titer
liver
tissu
bare
observ
dn
group
control
group
presum
dn
cell
may
play
role
inhibit
host
immun
respons
caus
liver
injuri
nevertheless
viru
replic
clearanc
appear
reach
dynam
balanc
process
follow
cytotox
assay
reveal
infect
dn
cell
show
signific
cytotox
effect
virusspecif
cell
sinc
virusspecif
cell
play
key
role
caus
liver
damag
result
made
sensibl
explan
surviv
increas
improv
liver
histolog
recipi
mice
adopt
transfer
experi
transwel
experi
indic
cellcel
contact
necessari
cytotox
mediat
dn
cell
moreov
fasfasl
pathway
instead
perforingranzym
pathway
play
vital
part
dn
cell
kill
thu
presum
infect
mice
dn
cell
rapidli
prolifer
follow
develop
liver
inflamm
contribut
control
liver
injuri
kill
virusspecif
cell
phenomenon
observ
agreement
describ
tcrab
dn
cell
abl
prevent
reject
skin
heart
allograft
specif
inhibit
cell
fasfasl
interact
howev
zhang
et
al
report
dn
cell
control
b
cell
respons
perforingranzymedepend
mechan
voelkl
also
report
human
dn
treg
elimin
effector
cell
fasfaslmedi
apoptosi
suppress
activ
cell
contactdepend
mechan
thu
seem
function
dn
treg
chang
accord
differ
phenotyp
specif
set
found
splenic
dn
cell
infect
mice
bear
distinct
array
phenotyp
tcrab
complet
differ
previous
describ
cell
meanwhil
dn
cell
show
rel
increas
product
ifnc
low
tnfa
report
diseas
model
dn
cell
differ
phenotyp
present
differ
cytokin
profil
autoimmun
diseas
like
sle
tcrab
dn
cell
major
produc
one
key
inflammatori
cytokin
involv
sle
result
suggest
dn
cell
contribut
pathogenesi
kidney
damag
patient
sle
mangabey
dn
cell
increas
express
ifnc
suggest
cell
may
capabl
perform
multipl
function
includ
helperlik
function
regulatori
function
latter
could
potenti
contribut
control
immun
activ
nonpathogen
siv
infect
studi
assum
dn
cell
may
degre
exert
role
cell
promot
viral
elimin
nevertheless
limit
quantiti
cytokin
constrain
power
viral
clearanc
allow
lowlevel
viral
persist
postul
delic
balanc
multipl
effect
dn
cell
contribut
viral
persist
model
conclus
report
herein
first
time
splenic
dn
cell
product
profound
immunomodulatori
effect
kill
viralspecif
cell
via
fasfasl
pathway
induc
viral
hepat
suggest
contribut
dn
cell
viral
persist
find
may
provid
rational
modul
dn
cell
manag
viral
hepat
author
financi
conflict
interest
